Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation.
Lin H, Wang L, Liu Z, Long K, Kong M, Ye D, Chen X, Wang K, Wu KK, Fan M, Song E, Wang C, Hoo RL, Hui X, Hallenborg P, Piao H, Xu A, Cheng KK.
Lin H, et al. Among authors: cheng kk.
Adv Sci (Weinh). 2022 Jul;9(20):e2200742. doi: 10.1002/advs.202200742. Epub 2022 May 7.
Adv Sci (Weinh). 2022.
PMID: 35524581
Free PMC article.